Dual effects of tumor necrosis factor alpha on myocardial injury following prolonged hypoperfusion of the heart

References

• Abd-Elfattah AS, Ding M, Jessen ME, Wechsler AS. (2012). On-pump inhibition of es-ENT1 nucleoside transporter and adenosine deaminase during aortic crossclamping entraps intracellular adenosine and protects against reperfusion injury: role of adenosine A1 receptor. J Thorac Cardiovasc Surg, 144, 243–9
   Google Scholar
• Aggarwal BB, Shishodia S, Takada Y, et al. (2006). TNF blockade: an inflammatory issue. Ernst Schering Res Found Workshop, 161–86
   Google Scholar
• Asgeri M, Ahmadpour F, Negargar S, et al. (2011). The comparative myocardial protection by propofol and isoflurane in an in vivo model of ischemia reperfusion. Semin Cardiothorac Vasc Anesth, 15, 56–65
   Google Scholar
• Baumgarten G, Knuefermann P, Nozaki N, et al. (2001). In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J Infect Dis, 183, 1617–24
   PubMed Web of Science ®Google Scholar
• Belosjorow S, Bolle I, Duschin A, et al. (2003). TNF-alpha antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits. Am J Physiol Heart Circ Physiol, 284, H927–30
   Google Scholar
• Belosjorow S, Schulz R, Dorge H, et al. (1999). Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits. Am J Physiol, 277, H2470–5
   PubMedGoogle Scholar
• Binck BW, Tsen MF, Islas M, et al. (2005). Bone marrow-derived cells contribute to contractile dysfunction in endotoxic shock. Am J Physiol Heart Circ Physiol, 288, H577–83
   Google Scholar
• Canton M, Skyschally A, Menabo R, et al. (2006). Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization. Eur Heart J, 27, 875–81
   PubMed Web of Science ®Google Scholar
• Cserni G, Amendoeira I, Bianchi S, et al. (2011). Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitions. Eur J Cancer, 47, 887–94
   Google Scholar
• Dhalla NS, Elmoselhi AB, Hata T, Makino N. (2000). Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res, 47, 446–56
   PubMed Web of Science ®Google Scholar
• Dorge H, Schulz R, Belosjorow S, et al. (2002). Coronary microembolization: the role of TNF-alpha in contractile dysfunction. J Mol Cell Cardiol, 34, 51–62
   PubMed Web of Science ®Google Scholar
• Fallach R, Shainberg A, Avlas O, et al. (2010). Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia. J Mol Cell Cardiol, 48, 1236–44
   Google Scholar
• Fan MH, Wong KL, Wu S, et al. (2010). Preconditioning with Porphyromonas gingivalis lipopolysaccharide may confer cardioprotection and improve recovery of the electrically induced intracellular calcium transient during ischemia and reperfusion. J Periodontal Res, 45, 100–8
   Google Scholar
• Fedulov AV, Ses TP, Gavrisheva NA, et al. (2005). Serum TGF-beta 1 and TNF-alpha levels and cardiac fibrosis in experimental chronic renal failure. Immunol Invest, 34, 143–52
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG, Shimoni S, Chang SM, et al. (2002a). Evidence for an active inflammatory process in the hibernating human myocardium. Am J Pathol, 160, 1425–33
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG, Smith CW, Entman ML. (2002b). The inflammatory response in myocardial infarction. Cardiovasc Res, 53, 31–47
   PubMed Web of Science ®Google Scholar
• Frantz S, Kelly RA, Bourcier T. (2001). Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J Biol Chem, 276, 5197–203
   PubMed Web of Science ®Google Scholar
• Frantz S, Kobzik L, Kim YD, et al. (1999). Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest, 104, 271–80
   PubMed Web of Science ®Google Scholar
• Heusch G. (2013). Cardioprotection: chances and challenges of its translation to the clinic. Lancet, 381, 166–75
   PubMed Web of Science ®Google Scholar
• Janssen M, Koster JF, Bos E, de Jong JW. (1993). Malondialdehyde and glutathione production in isolated perfused human and rat hearts. Circ Res, 73, 681–8
   Google Scholar
• Javadzadegan H, Nezami N, Ghobadi K, et al. (2010). High-sensitivity C-reactive protein (hs-CRP) and tumor necrotizing factor-alpha (TNF-alpha) after on- and off- pump coronary artery bypass grafting. HSR Proc Intensive Care Cardiovasc Anesth, 2, 27–33
   Google Scholar
• King SB, 3rd, Smith SC, Jr Hirshfeld JW, Jr et al. (2008). 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation, 117, 261–95
   PubMed Web of Science ®Google Scholar
• Kleinbongard P, Heusch G, Schulz R. (2010). TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther, 127, 295–314
   PubMed Web of Science ®Google Scholar
• Klopp AH, Lacerda L, Gupta A, et al. (2010). Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One, 5, e12180
   Google Scholar
• Kubota T, Miyagishima M, Frye CS, et al. (2001). Overexpression of tumor necrosis factor- alpha activates both anti- and pro-apoptotic pathways in the myocardium. J Mol Cell Cardiol, 33, 1331–44
   PubMedGoogle Scholar
• Kurrelmeyer KM, Michael LH, Baumgarten G, et al. (2000). Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA, 97, 5456–61
   PubMed Web of Science ®Google Scholar
• Lacerda L, Pusztai L, Woodward WA. (2010). The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches. Drug Resist Updat, 13, 99–108
   PubMed Web of Science ®Google Scholar
• Ladeira MS, Andrade VA, Gomes ER, et al. (2010). Highly efficient siRNA delivery system into human and murine cells using single-wall carbon nanotubes. Nanotechnology, 21, 385101. doi:10.1088/0957-4484/21/38/385101
   PubMed Web of Science ®Google Scholar
• Lecour S, Maupoil V, Siri O, et al. (1999). Electron spin resonance detection of nitric oxide generation in major organs from LPS-treated rats. J Cardiovasc Pharmacol, 33, 78–85
   Google Scholar
• Liao R, Podesser BK, Lim CC. (2012). The continuing evolution of the Langendorff and ejecting murine heart: new advances in cardiac phenotyping. Am J Physiol Heart Circ Physiol, 303, H156–67
   PubMed Web of Science ®Google Scholar
• Lucchinetti E, Jamnicki M, Fischer G, Zaugg M. (2008). Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts. Anesth Analg, 106, 17–23, table of contents
   Google Scholar
• Mair J. (1999). Tissue release of cardiac markers: from physiology to clinical applications. Clin Chem Lab Med, 37, 1077–84
   PubMed Web of Science ®Google Scholar
• Meldrum DR. (1998). Tumor necrosis factor in the heart. Amer J Physiol, 274, R577–95
   PubMed Web of Science ®Google Scholar
• Meldrum DR, Cain BS, Cleveland JC, Jr et al. (1997). Adenosine decreases post-ischaemic cardiac TNF-alpha production: anti-inflammatory implications for preconditioning and transplantation. Immunology, 92, 472–7
   Google Scholar
• Meldrum DR, Cleveland JC, Jr Cain BS, et al. (1998). Increased myocardial tumor necrosis factor-alpha in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. Ann Thorac Surg, 65, 439–43
   PubMed Web of Science ®Google Scholar
• Murry CE, Jennings RB, Reimer KA. (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 74, 1124–36
   PubMed Web of Science ®Google Scholar
• Nader ND, Li CM, Khadra WZ, et al. (2004). Anesthetic myocardial protection with sevoflurane. J Cardiothorac Vasc Anesth, 18, 269–74
   PubMed Web of Science ®Google Scholar
• Nelson SK, Wong GH, McCord JM. (1995). Leukemia inhibitory factor and tumor necrosis factor induce manganese superoxide dismutase and protect rabbit hearts from reperfusion injury. J Mol Cell Cardiol, 27, 223–9
   PubMedGoogle Scholar
• Oyama J, Blais C, Jr Liu X, et al. (2004). Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation, 109, 784–9
   PubMed Web of Science ®Google Scholar
• Ren X, Wang Y, Jones WK. (2004). TNF-alpha is required for late ischemic preconditioning but not for remote preconditioning of trauma. J Surg Res, 121, 120–9
   Google Scholar
• Skyschally A, Gres P, Hoffmann S, et al. (2007). Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res, 100, 140–6
   PubMed Web of Science ®Google Scholar
• Steenbergen C, Murphy E, Watts JA, London RE. (1990). Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res, 66, 135–46
   PubMed Web of Science ®Google Scholar
• Stern MD, Silverman HS, Houser SR, et al. (1988). Anoxic contractile failure in rat heart myocytes is caused by failure of intracellular calcium release due to alteration of the action potential. Proc Natl Acad Sci USA, 85, 6954–8
   PubMed Web of Science ®Google Scholar
• Smith RM, Suleman N, McCarthy J, Sack MN. (2002). Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene. Cardiovasc Res, 55, 553–60
   Google Scholar
• Tingberg E, Ohlin AK, Gottsater A, Ohlin H. (2006). Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy. Int J Cardiol, 112, 275–81
   Google Scholar
• Zacharowski K, Frank S, Otto M, et al. (2000). Lipoteichoic acid induces delayed protection in the rat heart: A comparison with endotoxin. Arterioscler Thromb Vasc Biol, 20, 1521–8
   PubMed Web of Science ®Google Scholar
• Zhang M, Xu Y-J, Saini HK, et al. (2005). TNF-alpha as a potential mediator of cardiac dysfunction due to intracellular Ca2+-overload. Biochem Biophys Res Commun, 327, 57–63
   PubMed Web of Science ®Google Scholar